Development of De Novo Anti-HLA Antibodies in Pediatric Heart Transplant Recipients

被引:0
|
作者
Chen, C. K. [1 ]
Manlhiot, C. [1 ]
Conway, J. [1 ]
Allain-Rooney, T. [1 ]
McCrindle, B. W. [1 ]
Tinckam, K. [2 ]
Dipchand, A. I. [1 ]
机构
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] Univ Hlth Network, Multiorgan Transplant Program, Toronto, ON, Canada
来源
关键词
D O I
10.1016/j.healun.2013.01.471
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
517
引用
收藏
页码:S193 / S193
页数:1
相关论文
共 50 条
  • [11] The Development of De Novo Anti-hla Antibodies after Heart Transplant is Related to the Development of Rejection Depending of Their Complement Fixing Capability
    Farrero Torres, Marta
    Rigal, Marcelo J. Pando
    Valantine, Hannah
    Smith, Spenser B.
    Khush, Kiran
    CIRCULATION, 2012, 126 (21)
  • [12] DE NOVO DEVELOPMENT OF ANTI-HLA ANTIBODIES IN LUNG TRANSPLANT RECIPIENTS WITH PREEXISTING DSA IS RELATED TO PIRCHE-II SCORE
    Lobashevsky, Andrew L.
    Niemann, Matthias
    Kowinsk, Brenda
    Higgins, Nancy G.
    Roe, David W.
    Hage, Chadi
    HUMAN IMMUNOLOGY, 2019, 80 : 147 - 147
  • [13] DE NOVO ANTI-HLA ANTIBODIES IN PRE-TRANSPLANT UNSENSITIZED PATIENTS
    Tafulo, Sandra
    Malheiro, Jorge
    Osorio, Ermelinda
    Mendes, Cecilia
    Freitas, Fatima
    TISSUE ANTIGENS, 2014, 84 (01): : 90 - 91
  • [14] De-novo donor-specific anti-HLA antibodies in islet cell transplant recipients in Australia
    Hue, S. M.
    Torpy, D. J.
    Bennett, G.
    Kay, T. W.
    Thomas, H. E.
    Goodman, D.
    Loudovaris, T.
    O'Connell, P. J.
    Radford, T.
    Drogemuller, C. J.
    Coates, P. T.
    TRANSPLANTATION, 2016, 100 (07) : S405 - S405
  • [15] ANTI-HLA ANTIBODIES IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS - ANALYSIS OF POTENTIAL TRIGGERS
    Pradhan, Subal K.
    Bitzan, Martin
    Bell, Lorraine
    Saw, Chee Loong
    HUMAN IMMUNOLOGY, 2015, 76 : 60 - 60
  • [16] Clinical implication of non-complement-binding de novo donor-specific anti-HLA antibodies in heart transplant recipients
    Sato, Takuma
    Seguchi, Osamu
    Nakajima, Seiko
    Matsuda, Sachi
    Kanaumi, Yoshiaki
    Wada, Kyoichi
    Yanase, Masanobu
    Ueda, Hatsue
    Fukushima, Norihide
    Nakatani, Takeshi
    TRANSPLANTATION, 2016, 100 (07) : S825 - S825
  • [17] Risk Factors and Consequences of De Novo Anti-HLA Donor Specific Antibodies in Kidney Transplant Recipients: The Force Awakens
    Javaid, B.
    Rosen-Bronson, S.
    Li, D.
    Awwad, M.
    Gilbert, A.
    Ghasemian, S.
    Verbesey, J.
    Abrams, P.
    Grafals, M.
    Fenton, J.
    Cannon, C.
    Rapisura, J.
    Moore, J.
    Cooper, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 411 - 411
  • [18] Tacrolimus and sirolimus reduces de novo anti-HLA antibodies in kidney transplant receptors
    Morales-Buenrostro, Luis E.
    Castro, Rene
    Terasaki, Paul I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 443 - 444
  • [19] De Novo Anti-HLA Antibodies in Renal Allograft Recipients: A Cross-Section Study
    Sanchez-Fructuoso, A. I.
    Santiago, J. L.
    Perez-Flores, I.
    Calvo Romero, N.
    Valero, R.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (08) : 2874 - 2876
  • [20] Effect of SARS-CoV-2 Infection on Anti-HLA Antibodies and De Novo DSA Incidence in Lung Transplant Recipients
    Zajacova, A.
    Dvorackova, E.
    Vyskocilova, K.
    Casas-Mendez, L.
    Kotowski, T.
    Valentova-Bartakova, L.
    Fila, L.
    Lischke, R.
    Havlin, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S158 - S158